Drug
Surufatinib Combined With Camrelizumab
Surufatinib Combined With Camrelizumab: highest development phase Phase 2/3, developed by Hutchmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Hutchmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine NCT06361888 | Phase 2/3 | Metastatic Pancreatic Cancer |
Latest
No recent events.
Follow Surufatinib Combined With Camrelizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.